Between millionaires blasting Gen-Yers for eating avocado toasts and reports of millennials spending $96 billion dollars on food, people love talking about twentysomethings spending habits. And while no one wants to discuss sexy topics like soaring college loans, unaffordable housing and the lagging job market, stashing money in the bank is one way you can hit your financial goals. Despite coming-of-age in the worst economic climate since the Great Depression.
In honor of turning over a new leaf this fall, we’ve rounded up saving tips from credit card experts, personal finance gurus and podcasts hosts. Because saving money in your 20s sets you up for your future. Whether that’s a house with a white picket fence or a yurt in an intentional living community, it pays to plan ahead.
Saving money in your 20s is the best way to hit your longterm financial goals.
learning the stock market: ZELTIQ Aesthetics, Inc.(ZLTQ)
- [By James E. Brumley]
This week, Botox maker Allergan plc (NYSE:AGN) shelled out $2.5 billion for body-sculpting outfit Zeltiq Aesthetics Inc (NASDAQ:ZLTQ). The pairing is a nice opportunity for both organizations to cross-sell to one another’s customers. Allergan’s Botox customers seeking a more youthful face will also likely want the better body Zeltiq Aesthetics provides, and Zeltiq Aesthetics’ customers are natural candidates for Botox injections that Allergan facilitates.
The acquisition, though, is just a microcosm of a bigger trend that’s still picking up steam. That trend is, as the industry’s capabilities to restore youth, slim waists, whiten teeth, improve skin, and nip and tuck here and there improve with science, demand for these increasingly effective ‘tweaks’ is soaring. Names like the aforementioned Allergan, Cynosure, Inc. (NASDAQ:CYNO), Zeltiq Aesthetics and Align Technology, Inc. (NASDAQ:ALGN) are all driving impressive growth. And, they’re all looking to expand their footprint in front of the rising tide.
Not every name riding this growth wave is going to be a large cap stock or a household name though. There’s a small cap stock called RepliCel Life Sciences (OTCMKTS:REPCF, CVE:RP) that could soon be turning a lot of heads not just of investors, but of potential suitors.
In simplest terms, RepliCel Life Sciences has two key sciences that serve as the foundation for three therapies and one medical device.
The first of the two biological premises is based on the company’s non-bulbar dermal sheath fibroblast platform, and currently includes treatments for chronic tendinosis and skin aging. The second is the company’s dermal sheath cup (DSC) cell platform for the treatment of androgenetic alopecia (pattern baldness).
The three marketable products those two sciences are driving are RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair regeneration. The device is a dermal injector – currently categorized as R
learning the stock market: Century Casinos, Inc.(CNTY)
- [By Lisa Levin]
Century Casinos, Inc. (NASDAQ: CNTY) shares dropped 15 percent to $7.77. Century Casinos priced its 4.25 million share offering at $7.50 per share.
learning the stock market: Tencent Holdings Ltd (700)
- [By Belinda Cao]
Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.
learning the stock market: WildHorse Resource Development Corporation (WRD)
- [By Paul Ausick]
WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.
learning the stock market: Cinemark Holdings Inc(CNK)
- [By Jon C. Ogg]
24/7 Wall St. covers many of the top analyst upgrades and downgrades each morning of the week. The downgrade brigade included a Credit Suisse report on Cinemark Holdings Inc. (NYSE: CNK) that effectively gave the movie cinema chain the equivalent of a “Sell” rating. It was actually a negative view on the entire movie chain sector.
- [By Monica Gerson]
Cinemark Holdings, Inc. (NYSE: CNK) is projected to report its quarterly earnings at $0.46 per share on revenue of $699.23 million.
Aecom (NYSE: ACM) is expected to report its quarterly earnings at $0.72 per share on revenue of $4.55 billion.
learning the stock market: Capella Education Company(CPLA)
- [By Lisa Levin]
Shares of Capella Education Company (NASDAQ: CPLA) got a boost, shooting up 32 percent to $86.60. Strayer Education Inc (NASDAQ: STRA) and Capella Education agreed to an all-stock merger. Capella Education also posted upbeat quarterly earnings.